Hints and tips:
...Company Q3 Wednesday Bank of England governor Andrew Bailey, European Central Bank governing council member Gabriel Makhlouf, Aviva chief executive Amanda Blanc, Bank of Ireland chief executive Myles O’...
...Join the FT’s Peggy Hollinger as she interviews Michael O’Leary, the chief executive of Ryanair, on all this and more for our next DD Forum on April 21....
...At a recent FT conference, Ryanair airline boss Michael O’Leary said bluntly: “I suspect an awful lot of the environmental agenda and targets will be put on the backburner for a number of years.”...
...Strigini is a former president of Novartis Oncology and has also worked at several other drug companies....
...and Venclexta — and virology — with drugs used to treat hepatitis C — among other areas....
...That curbs the pressure to cut prices, in contrast with pills with generic competition or, for example, a hepatitis C drug with a rival that might also be effective....
...Other trade buyers — including rating agency Moody’s, Rupert Murdoch’s News Corp and Germany’s Axel Springer — found the price tag too steep....
...Take Merck, which recently announced a series of rollbacks, including a 60 per cent price cut for Zepatier, a medicine for hepatitis C....
...The news comes a day after Novartis, the Swiss drugmaker, said it had cancelled a round of planned increases....
...After news broke last week that AT&T and Novartis had respectively paid $600,000 and $1.2m to Michael Cohen, both companies’ chief executives told their employees that hiring Donald Trump’s personal lawyer...
...It is hard to find a management team that is willing to give up their spots in the c-suite without being paid a premium large enough to make a deal unattractive to a buyer....
...Others include Novartis, the Swiss drugs maker, Columbus Nova, a New York-based investment firm, and Korea Aerospace Industries. In all, Mr Cohen made $2.4m in fees simply because he knew Mr Trump....
...Daniel O'Day, chief executive of Roche, said that 16 per cent growth in China in the most recent quarter indicated “the ability for China to be able to launch and seek reimbursement for newer oncology medicines...
...“[O]ur Washington DC team’s vetting process clearly failed, and I take responsibility for that.”...
...After growing up in the Washington, D.C., area and getting his MBA at the University of Utah, he’d come out to California in the late 1970s and never left....
...Novartis, for example, was fined by South Korean authorities last year and had products suspended for three months on allegations of offering payments to doctors to recommend its drugs....
...This “smart contact lens”, now under development with Novartis, will enable people with diabetes to monitor themselves continuously by measuring the glucose in their tears....
...Sarah O’Connor Our robot era demands a different approach to retraining “In the age of the robots, it will not be enough to help people be resilient....
...Some investors thought Juno, a potential third entrant in what is still a small market, would struggle to mount an effective challenge to Novartis and Gilead....
...“For hepatitis C we have over a 99 per cent compliance rate with taking the medication and a 100 per cent cure rate,” he says....
...Novartis was given the green light to use it in children and young adults with a type of leukaemia....
...(FT) News round-up Malaria 'game changer' Novartis' KAF 156 — developed with the Medicines for Malaria Venture — is the first new malaria drug for 20 years....
...The companies ranging from Airbus to Bosch to Novartis are vulnerable because they are emblems of the global supply chains that Mr Trump has disdained while also being creators of the kind of manufacturing...
...• Kate O’Neill has been named head of corporate development at Jupiter Asset Management, a newly created role. Ms O’Neill will build a team covering corporate strategy....
...The Car-T field is crowded, too, with rival treatments from Novartis and Juno. The highest analyst price target on Kite before the acquisition was just $155....
International Edition